These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23373553)

  • 1. Prospective evaluation of the dosing regimen of vancomycin in children of different weight categories.
    Nassar L; Hadad S; Gefen A; Shachor-Meyouhas Y; Mashiach T; Krivoy N; Kassis I
    Curr Drug Saf; 2012 Nov; 7(5):375-81. PubMed ID: 23373553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vancomycin dosing and target attainment in children.
    Hwang D; Chiu NC; Chang L; Peng CC; Huang DT; Huang FY; Chi H
    J Microbiol Immunol Infect; 2017 Aug; 50(4):494-499. PubMed ID: 26462708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AUC versus peak-trough dosing of vancomycin: applying new pharmacokinetic paradigms to an old drug.
    Brown DL; Lalla CD; Masselink AJ
    Ther Drug Monit; 2013 Aug; 35(4):443-9. PubMed ID: 23851909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of vancomycin dosing for complicated infections in pediatric patients.
    Durham SH; Simmons ML; Mulherin DW; Foland JA
    Hosp Pediatr; 2015 May; 5(5):276-81. PubMed ID: 25934812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of optimal initial dosing regimen with vancomycin pharmacokinetics model in very low birth weight neonates.
    Kato H; Hagihara M; Nishiyama N; Koizumi Y; Mikamo H; Matsuura K; Yamagishi Y
    J Infect Chemother; 2017 Mar; 23(3):154-160. PubMed ID: 28017667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosing vancomycin in the super obese: less is more.
    Crass RL; Dunn R; Hong J; Krop LC; Pai MP
    J Antimicrob Chemother; 2018 Nov; 73(11):3081-3086. PubMed ID: 30203073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved vancomycin dosing in children using area under the curve exposure.
    Le J; Bradley JS; Murray W; Romanowski GL; Tran TT; Nguyen N; Cho S; Natale S; Bui I; Tran TM; Capparelli EV
    Pediatr Infect Dis J; 2013 Apr; 32(4):e155-63. PubMed ID: 23340565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Desired vancomycin trough serum concentration for treating invasive methicillin-resistant Staphylococcal infections.
    Frymoyer A; Guglielmo BJ; Hersh AL
    Pediatr Infect Dis J; 2013 Oct; 32(10):1077-9. PubMed ID: 23652479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of vancomycin in extremely obese patients with suspected or confirmed Staphylococcus aureus infections.
    Adane ED; Herald M; Koura F
    Pharmacotherapy; 2015 Feb; 35(2):127-39. PubMed ID: 25644478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population Pharmacokinetic Assessment of Vancomycin Dosing in the Large Pediatric Patient.
    Moffett BS; Ivaturi V; Morris J; Akcan Arikan A; Dutta A
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of clinical outcome in children and adolescents receiving vancomycin for invasive infections due to methicillin-resistant Staphylococcus aureus: impact of increasing vancomycin MICs.
    Arun A; Swamy S; Jacob K; Sharma R; Kohlhoff SA; Hammerschlag MR
    Minerva Pediatr; 2018 Jun; 70(3):207-211. PubMed ID: 28006894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Multicenter Retrospective Study of Vancomycin Dosing by Weight Measures in Children.
    Khare M; Haag MB; Kneese G; Austin JP; Perlman J; Azim A; Orsi C; Foster BA
    Hosp Pediatr; 2021 Nov; 11(11):e289-e296. PubMed ID: 34645692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innovative approaches to optimizing the delivery of vancomycin in individual patients.
    Pai MP; Neely M; Rodvold KA; Lodise TP
    Adv Drug Deliv Rev; 2014 Nov; 77():50-7. PubMed ID: 24910345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin serum concentrations in pediatric oncologic/hematologic intensive care patients.
    Silva DC; Seixas GT; Araujo OR; Arduini RG; Carlesse FA; Petrilli AS
    Braz J Infect Dis; 2012; 16(4):361-5. PubMed ID: 22846125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vancomycin dosing in children and young adults: back to the drawing board.
    Camaione L; Elliott K; Mitchell-Van Steele A; Lomaestro B; Pai MP
    Pharmacotherapy; 2013 Dec; 33(12):1278-87. PubMed ID: 24019205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vancomycin dosing in children: what is the question?
    Cole TS; Riordan A
    Arch Dis Child; 2013 Dec; 98(12):994-7. PubMed ID: 23956256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Relationship Between Vancomycin Trough Concentrations and AUC/MIC Ratios in Pediatric Patients: A Qualitative Systematic Review.
    Tkachuk S; Collins K; Ensom MHH
    Paediatr Drugs; 2018 Apr; 20(2):153-164. PubMed ID: 29344778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulase negative staphylococcal sepsis in neonates: do we need to adapt vancomycin dose or target?
    Padari H; Oselin K; Tasa T; Metsvaht T; Lõivukene K; Lutsar I
    BMC Pediatr; 2016 Dec; 16(1):206. PubMed ID: 27931193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion.
    Waineo MF; Kuhn TC; Brown DL
    J Clin Pharm Ther; 2015 Jun; 40(3):259-65. PubMed ID: 25865426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of a divided-load intravenous vancomycin dosing strategy for obese patients.
    Denetclaw TH; Yu MK; Moua M; Dowling TC; Steinke D
    Ann Pharmacother; 2015 Aug; 49(8):861-8. PubMed ID: 25986008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.